| Net Cash Provided by (Used in) Operating Activities |
$431,887,000 |
USD |
23% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$124,464,000 |
USD |
-135% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$239,954,000 |
USD |
67% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
320,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
97,218,183 |
shares |
-4.9% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$66,945,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$302,716,000 |
USD |
125% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,383,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$543,098,000 |
USD |
-26% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$11,746,000 |
USD |
29% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,662,203,000 |
USD |
56% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$527,000,000 |
USD |
16% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$1,883,000 |
USD |
2.3% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$2,117,000 |
USD |
-38% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$1,417,000 |
USD |
-12% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$10,342,000 |
USD |
145% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$867,000 |
USD |
-24% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$552,509,000 |
USD |
1.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$539,715,000 |
USD |
-27% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$52,193,000 |
USD |
43% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$141,690,000 |
USD |
21% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |